Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samiran Panda

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Human Vaccines & Immunotherapeutics|March 21, 2024
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adultsPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
BMC Infectious Diseases|November 17, 2022
A case control investigation of COVID-19 associated mucormycosis in IndiaTanu Anand, Aparna Mukherjee, Aanchal Satija, et al.
The New England Journal of Medicine|January 29, 2025
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible TuberculosisLorenzo Guglielmetti, Uzma Khan, Gustavo E Velásquez, et al.
The Lancet Regional Health. Southeast Asia|January 17, 2023
Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled studyPrasad S Kulkarni, Abhijit Kadam, Sheela Godbole, et al.
Nature Communications|March 3, 2021
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaquesPragya D Yadav, Raches Ella, Sanjay Kumar, et al.
Journal of Infection and Public Health|November 10, 2023
Prevalence and factors associated with tuberculosis infection in IndiaSriram Selvaraju, Banurekha Velayutham, Raghuram Rao, et al.
Viruses|June 2, 2021
An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of IndiaPragya D Yadav, Dimpal A Nyayanit, Triparna Majumdar, et al.
BMJ (Clinical Research Ed.)|April 10, 2026
Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial)Manjula Singh, Sindhu Joshi, Vikram Vohra, et al.
Plos One|March 10, 2022
Psychological distress and burnout among healthcare worker during COVID-19 pandemic in India-A cross-sectional studyGeetha R Menon, Jeetendra Yadav, Sumit Aggarwal, et al.
International Journal of Disaster Risk Reduction : IJDRR|June 12, 2023
Gender differences in COVID-19 knowledge, risk perception, and public stigma among the general community: Findings from a nationwide cross-sectional study in IndiaA Stephen, Saritha Nair, Aparna Joshi, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Human Vaccines & Immunotherapeutics|March 21, 2024
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adultsPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
BMC Infectious Diseases|November 17, 2022
A case control investigation of COVID-19 associated mucormycosis in IndiaTanu Anand, Aparna Mukherjee, Aanchal Satija, et al.
The New England Journal of Medicine|January 29, 2025
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible TuberculosisLorenzo Guglielmetti, Uzma Khan, Gustavo E Velásquez, et al.
The Lancet Regional Health. Southeast Asia|January 17, 2023
Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled studyPrasad S Kulkarni, Abhijit Kadam, Sheela Godbole, et al.
Nature Communications|March 3, 2021
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaquesPragya D Yadav, Raches Ella, Sanjay Kumar, et al.
Journal of Infection and Public Health|November 10, 2023
Prevalence and factors associated with tuberculosis infection in IndiaSriram Selvaraju, Banurekha Velayutham, Raghuram Rao, et al.
Viruses|June 2, 2021
An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of IndiaPragya D Yadav, Dimpal A Nyayanit, Triparna Majumdar, et al.
BMJ (Clinical Research Ed.)|April 10, 2026
Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial)Manjula Singh, Sindhu Joshi, Vikram Vohra, et al.
Plos One|March 10, 2022
Psychological distress and burnout among healthcare worker during COVID-19 pandemic in India-A cross-sectional studyGeetha R Menon, Jeetendra Yadav, Sumit Aggarwal, et al.
International Journal of Disaster Risk Reduction : IJDRR|June 12, 2023
Gender differences in COVID-19 knowledge, risk perception, and public stigma among the general community: Findings from a nationwide cross-sectional study in IndiaA Stephen, Saritha Nair, Aparna Joshi, et al.
Pageof 11